Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cap-dependent endonuclease-IN-5 is a potent inhibitor of cap-dependent nucleic acid endonucleases (CEN). cap-dependent endonuclease-IN-5 has good influenza virus inhibitory activity and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | Cap-dependent endonuclease-IN-5 is a potent inhibitor of cap-dependent nucleic acid endonucleases (CEN). cap-dependent endonuclease-IN-5 has good influenza virus inhibitory activity and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties. |
Molecular Weight | 553.6 |
Formula | C27H21F2N3O4S2 |
CAS No. | 2416258-53-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cap-dependent endonuclease-IN-5 2416258-53-0 inhibitor inhibit